吉林大学学报(医学版) ›› 2023, Vol. 49 ›› Issue (5): 1234-1242.doi: 10.13481/j.1671-587X.20230517

• 基础研究 • 上一篇    

沉默CDKL1基因通过调控PTEN/Akt/mTOR信号通路对乳腺癌MCF-7细胞增殖和侵袭的抑制作用

赵月生,李祖彬,刘海鸥,陶昆麟,赵齐海,李娜()   

  1. 齐齐哈尔医学院附属第三医院乳腺外科, 黑龙江 齐齐哈尔 161000
  • 收稿日期:2022-10-14 出版日期:2023-09-28 发布日期:2023-10-26
  • 通讯作者: 李娜 E-mail:loyse2279@163.com
  • 作者简介:赵月生(1982-),男,河北省邢台市人,副主任医师,主要从事乳腺癌基础和临床方面的研究。
  • 基金资助:
    黑龙江省卫健委科技计划项目(20210404010197)

Inhibitory effect of silencing CDKL1 gene on proliferation and invasion of breast cancer MCF-7 cells by regulating PTEN/Akt/mTOR signaling pathway

Yuesheng ZHAO,Zubin LI,Haiou LIU,Kunlin TAO,Qihai ZHAO,Na LI()   

  1. Department of Breast Surgery,Third Affiliated Hospital,Qiqihar Medical College,Qiqihar City,Heilongjiang Province,Qiqihar 161000,China
  • Received:2022-10-14 Online:2023-09-28 Published:2023-10-26
  • Contact: Na LI E-mail:loyse2279@163.com

摘要:

目的 探讨细胞周期蛋白依赖性蛋白样激酶1(CDKL1)基因沉默对乳腺癌MCF-7细胞增殖、侵袭和转移的影响,并阐明其可能的作用机制。 方法 选择乳腺癌MCF-7细胞作为研究对象,采用小干扰RNA技术(siRNA)沉默CDKL1基因表达。采用1 μmol·L-1 磷酸酶和张力蛋白同源物(PTEN)抑制剂BpV或10 μmol·L-1 蛋白激酶B(Akt)激动剂SC79进行干预。取对数生长期MCF-7细胞,分为空白对照组(MCF-7细胞不作任何处理)、转染对照(siRNA-NC)组(MCF-7细胞转染siRNA-NC质粒)、siRNA-CDKL1组(MCF-7细胞转染siRNA-CDKL1质粒)、siRNA-CDKL1+PTEN抑制剂BpV(siRNA-CDKL1+BpV)组(转染siRNA-CDKL1的MCF-7细胞,再采用1 μmol·L-1 PTEN抑制剂BpV处理2 h)和siRNA-CDKL1+Akt激动剂SC79(siRNA-CDKL1+SC79)组(转染siRNA CDKL1的MCF-7细胞,再采用10 μmol·L-1 Akt激动剂SC79处理2 h)。采用实时荧光定量PCR(RT-qPCR)和Western blotting法检测各组乳腺癌MCF-7细胞中CDKL1 mRNA和蛋白表达水平,CCK-8法检测各组乳腺癌MCF-7细胞增殖活性,EdU法检测各组乳腺癌MCF-7细胞中EdU阳性细胞率,细胞划痕愈合实验检测各组乳腺癌MCF-7细胞划痕愈合率,Transwell小室实验检测各组乳腺癌MCF-7细胞的迁移和侵袭细胞数,Western blotting法检测各组乳腺癌MCF-7细胞中基质金属蛋白酶2(MMP-2)、基质金属蛋白酶9(MMP-9)、PTEN、Akt、哺乳动物雷帕霉素靶蛋白(mTOR)、磷酸化Akt(p-Akt)和磷酸化mTOR(p-mTOR)蛋白表达水平。 结果 与siRNA-NC组比较,siRNA-CDKL1组乳腺癌MCF-7细胞中CDKL1 mRNA和蛋白表达水平降低(P<0.01),细胞增殖活性降低(P<0.01),EdU阳性细胞率降低(P<0.01),乳腺癌MCF-7细胞迁移和侵袭细胞数降低(P<0.01),细胞中MMP-2、MMP-9、p-Akt和p-mTOR蛋白表达水平降低(P<0.01),PTEN蛋白表达水平升高(P<0.01)。与siRNA-CDKL1组比较,siRNA-CDKL1+BpV组和siRNA-CDKL1+SC79组乳腺癌MCF-7细胞增殖活性升高(P<0.01),EdU阳性细胞率升高(P<0.01),迁移和侵袭细胞数增加(P<0.01),细胞中MMP-2、MMP-9、p-Akt和p-mTOR蛋白表达水平升高(P<0.01),PTEN蛋白表达水平降低(P<0.01)。 结论 CDKL1基因的沉默可以抑制乳腺癌MCF-7细胞的增殖、侵袭和转移能力,其作用机制可能与调控PTEN/Akt/mTOR信号通路有关。

关键词: 乳腺肿瘤, 周期蛋白依赖性蛋白样激酶1, 磷酸酶和张力蛋白同源物, 蛋白激酶, 哺乳动物雷帕霉素靶蛋白, 细胞增殖, 细胞迁移, 细胞侵袭

Abstract:

Objective To discuss the effect of cell division cyclin-dependentkinase like-1 (CDKL1) gene silencing on the proliferation, invasion, and metastasis of the breast cancer MCF-7 cells, and to clarify its possible mechanism. Methods The breast cancer MCF-7 cells were used as the research subjects, and the small interfering RNA (siRNA) technology was used to silence the expression of the CDKL1 gene. The intervention was performed by using 1 μmol·L-1 phosphatase and tension homolog (PTEN) inhibitor BpV or 10 μmol·L-1 protein kinase B(Akt) agonist SC79. The MCF-7 cells at logarithmic growth phase were divided into control group (MCF-7 cells without any treatment), transfection control (siRNA-NC) group (MCF-7 cells transfected with siRNA-NC plasmid), siRNA-CDKL1 group (MCF-7 cells transfected with siRNA-CDKL1 plasmid), siRNA-CDKL1+BpV group (MCF-7 cells transfected with siRNA-CDKL1 and treated with 1 μmol·L-1 PTEN inhibitor BpV for 2 h), and siRNA-CDKL1+SC79 group (MCF-7 cells transfected with siRNA-CDKL1 and treated with 10 μmol·L-1 Akt agonist SC79 for 2 h). Real-time fluorescence quantitative PCR (RT-qPCR) and Western blotting methods were used to detect the expression levels of CDKL1 mRNA and protein in the breast cancer MCF-7 cells in various groups; CCK-8 assay was used to detect the proliferation activities of the breast cancer MCF-7 cells in various groups;EdU assay was used to detect the rates of EdU positive cells in the breast cancer MCF-7 cells in various groups;cell scratch healing experiment was used to detect the scratch healing rates of the breast cancer MCF-7 cells in various groups; Transwell chamber assay was used to detect the numbers of migration and invasion breast cancer MCF-7 cells in various groups;Western blotting method was used to detect the expression levels of matrix metalloproteinase-2 (MMP-2), matrix metalloproteinase-9 (MMP-9), PTEN, Akt, mammalian target of rapamycin (mTOR), phosphorylated Akt (p-Akt), and phosphorylated mTOR (p-mTOR) proteins in the breast cancer MCF-7 cells in various groups. Results Compared with siRNA-NC group, the expression levels of CDKL1 mRNA and protein in the breast cancer MCF-7 cells in siRNA-CDKL1 group were decreased (P<0.01), the proliferation activity was decreased(P<0.01),the rate of EdU positive cells was decreased(P<0.01),and the numbers of migration and invasion cells were decreased (P<0.01), the expression levels of MMP-2, MMP-9, p-Akt, and p-mTOR proteins in the cells were decreased (P<0.01), and the expression level of PTEN protein was increased (P<0.01). Compared with siRNA-CDKL1 group, the proliferation activities of the breast cancer MCF-7 cells in siRNA-CDKL1+BpV group and siRNA-CDKL1+SC79 group were increased (P<0.01),the rate of EdU-positive cells was increased(P<0.01), the numbers of migration and invasion cells were increased(P<0.01), the expression levels of MMP-2, MMP-9, p-Akt, and p-mTOR proteins in the cells were increased(P<0.01),and the expression level of PTEN protein in the cells was decreased (P<0.01). Conclusion Silencing CDKL1 gene can inhibit the proliferation, invasion,and metastasis abilities of the breast cancer MCF-7 cells, and its mechanism may be related to the regulation of the PTEN/Akt/mTOR signaling pathway.

Key words: Breast neoplasm, Cyclin-dependentkinase like-1, Phosphatase and tension homolog, Protein kinase, Mammalian target of rapamycin, Cell proliferation, Cell migration, Cell invasion

中图分类号: 

  • R737.9